Research Center on Managed Care and Drug Abuse Treatment

描述（由申请人提供）： 在布兰迪斯/哈佛管理式医疗和药物滥用治疗中心的续约申请中，我们建议继续布兰迪斯大学施耐德卫生政策研究所和哈佛医学院卫生保健政策系之间的合作。布兰迪斯/哈佛中心于1995年9月成立，并获得了五年的支持奖。我们目前正在以无成本延期的方式运营第六年。建议该中心继续保持基本相同的行政结构和多学科研究人员和教育工作者小组。然而，我们已经通过中心核心扩大了临床，统计和方法学专业知识。我们还进一步强调技术转让是一项核心职能。 我们建议完善该中心的主题，从一个通用的重点管理式护理的第二代研究，审查的问题：“在管理式护理环境中，什么样的组织，管理，融资和支付的要素，使有效的药物滥用服务提供的差异？“围绕这一主题，我们计划了三个项目和一个试点项目，简述如下： 项目1：员工群体的物质滥用途径。该研究将使用来自管理健康网络（MHN）的索赔资格、授权和初始评估数据。此外，研究人员将对通过MHN接受药物滥用治疗的患者进行调查。该研究将调查综合员工援助计划/管理行为医疗保健和独立组件产品之间的药物滥用利用率和成本是否存在差异。 项目2：行为保健中的特征分析和激励措施。本研究评估了提供者分析激励措施对提高护理质量的贡献。结合准实验中断的时间序列和随机对照设计，该研究使用现有的数据，从低收入的一般援助客户谁接受药物滥用治疗的康涅狄格州的管理行为卫生保健计划。 项目3：在管理式护理中治疗尼古丁成瘾。这项对100个管理式护理组织（MCO）和3,000名医生的观察性研究将探讨可能影响MCO专注于治疗尼古丁使用和成瘾的力量，并将研究MCO如何实现其潜力，以实现对这些问题的认识和解决方式的改变。 试点：平等立法对药物滥用治疗的影响。这一试点项目将探讨在加州的私人健康保险中增加药物滥用治疗平等福利的增量影响的大规模研究的可行性。 整体

DESCRIPTION (provided by applicant): In this renewal request for the Brandeis/Harvard Center for Managed Care and Drug Abuse Treatment, we propose to continue the collaboration between Brandeis University's Schneider Institute for Health Policy and Harvard Medical School's Department of Health Care Policy. The Brandeis/Harvard Center began in September 1995 with an award for five years of support. We are currently operating in our sixth year on a no cost extension basis. It is proposed that the Center continue with largely the same administrative structure and multidisciplinary group of researchers and educators. However, we have expanded the clinical, statistical, and methodological expertise available through the Center core. We also have expanded our emphasis on technology transfer as a core function. We propose to refine the Center's theme from a generic focus on managed care to a second generation of studies that examine the question: "In a managed care environment, what elements of organization, management, financing and payment make a difference in effective drug abuse service delivery?" With this theme: we have planned three projects and a pilot described briefly below: Project 1: Substance Abuse Pathways for Employee Groups. The study will use claims eligibility, authorization, and initial assessment data from Managed Health Network (MHN). In addition, the investigators will conduct a survey of patients who have received substance abuse treatment through MHN. The study will investigate whether there are differences in substance abuse utilization and costs between integrated employee assistance programs/managed behavioral health care and stand-alone component products. Project 2: Profiling and Incentives in Behavioral Health Care. This research evaluates the contribution of provider profiling incentives to improve the quality of care. Combining a quasi-experimental interrupted time series and randomized-controlled designs, the study uses existing data from low-income general assistance clients who receive substance abuse treatment under the state of Connecticut's managed behavioral health care program. Project 3: Treating Nicotine Addiction in Managed Care. This observational study of 100 managed care organizations (MCOs) and 3,000 physicians will inquire into the forces that can influence MCOs to focus on treating nicotine use and addiction, and will examine how MCOs realize their potential to implement changes in the way these issues are recognized and addressed. Pilot: The Effect of Parity Legislation on Substance Abuse Treatment. This pilot will explore the feasibility for a large-scale study of the incremental impact of adding a parity benefit for substance abuse treatment to private health insurance in California. OVERALL